POU6F2


Summary: This gene encodes a member of the POU protein family characterized by the presence of a bipartite DNA binding domain, consisting of a POU-specific domain and a homeodomain, separated by a variable polylinker. The DNA binding domain may bind to DNA as monomers or as homo- and/or heterodimers, in a sequence-specific manner. The POU family members are transcriptional regulators, many of which are known to control cell type-specific differentiation pathways. This gene is a tumor suppressor involved in Wilms tumor (WT) predisposition. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.[provided by RefSeq, Oct 2009].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location
OMIM IDMIM:609062
PHARMGKB IDPA134969420
Map Location7p14.1

GO terms in POU6F2


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
CC IEA GO:0005634 nucleus
BP TAS GO:0006355 regulation of transcription, DNA-templated
BP IEA GO:0006357 regulation of transcription by RNA polymerase II
BP IEA GO:0006366 transcription by RNA polymerase II
BP TAS GO:0007402 ganglion mother cell fate determination
BP TAS GO:0007417 central nervous system development
Showing 1 to 6 of 12 rows rows per page

Gene expression in normal tissue: POU6F2

Gene-model tissue-cancer distribution: Bubble Plot

undefinetissue: undefine cancer: undefined model num: 0undefinedtissue: undefined cancer: PANCAN model num: 2

Gene-drug pathway distribution

Protein stability and degradation1ERK MAPK signaling1

Pathways in POU6F2


Loading, please wait...
Database
Pathway ID
Pathway Des.
No matching records found

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD353 PD0325901 1
iGMDRD309 17AAG 1
Showing 1 to 2 of 2 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in POU6F2

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​